Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

ECVAM News & Views

ECVAM News & Views ATLA 31, 471, 2003 471 — Metabolism (chairperson Dr S. Coecke, ECVAM, ECVAM’s Scientific Advisory Committee Italy; 1st meeting 24–25 September). (ESAC) — Neurotoxicity (chairperson Dr S. Coecke, ECVAM, New ESAC member Italy; 1st meeting 1–2 October). Professor Michael Ryan has been nominated to represent Ireland on the ESAC. — Pyrogenicity (chairperson Dr R. Bos, RIVM, The Netherlands; 1st meeting 7–8 October). — Good Cell Culture Practice (chairpersons Dr G. Stacy, ECVAM Workshops NIBSC, UK and G. Gstraunthaler, University of Innsbruck, Austria; meeting 20–21 October). Acute systemic toxicity A workshop (chaired by Laura Gribaldo, ECVAM) on Strategies to Replace In Vivo Acute Systemic Toxicity Testing was hosted by ECVAM on 15–18 September, and Visit of Michael Balls was attended by 26 experts from industry, academia and regulatory authorities. The first head of ECVAM, Professor Michael Balls, vis- ited ECVAM on 21–22 October, to participate in the Rabies vaccines meeting of the Task Force on Good Cell Culture Practice, The report of ECVAM workshop 48 on Three Rs and to discuss further collaboration with FRAME. Approaches in the Quality Control of Inactivated Rabies Vaccines (Bruckner et al.) has been published in ATLA (31, 429–454, 2003). ECVAM Staff Andrew Worth, and his action on Development, valida- Joint Research Centre (JRC) Enlargement tion and dissemination of quantitative structure–activ- Action ity relationships (QSARs), joined ECVAM on 1 October On 24–26 September, ECVAM organised and hosted a practical training course on In Vitro Methods for Pyrogenicity Testing, in cooperation with the Pharm- aceutical Control and Development Laboratory ECVAM’s Website (Budapest, Hungary), the University of Konstanz (Germany), Novartis (Basel, Switzerland) and the Paul The ECVAM website (http://www.ecvam.jrc.it) is updated Ehrlich Institute (Langen, Germany). Thirteen partici- on a regular basis, and now includes a list of workshops pants from Bulgaria, Cyprus, Hungary and Slovenia and task force meetings organised by ECVAM. attended the course. In cooperation with the European Resource Centre for Alternatives (EURCA) and InterNICHE, ECVAM organ- ised and held a workshop on 18–20 October in Konstancin ECVAM Publications (Poland) on Alternatives to the Use of Animals in Higher Education. Nineteen participants attended the workshop, Pessina, A., Albella, B., Bayo, M., Bueren, J., Brantom, from Bosnia-Herzogowina, Croatia, the Czech Republic, P., Casati, S., Coroera, C., Gagliardi, G., Foti, P., Hungary, Latvia, Lithuania, Poland, Romania, Slovakia, Parchment, R., Parent-Massin, D., Schoeters, G., Sibiril, Slovenia and Turkey. The presentations are available on Y., Van Den Heuvel, R. & Gribaldo, L. (2003). Application the EURCA website (http://www.eurca.org). of the CFU-GM assay to predict acute drug-induced neu- tropenia: an international blind trial to validate a predic- tion model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicological Sciences 75, ECVAM Task Forces 355–367. Meetings of the following Task Forces have been held at Diodovich, C., Malerba, I., Bowe, G., Acquati, F., Bianchi, ECVAM. M.G., Taramelli, R., Parent-Massin, D. & Gribaldo, L. (2003). Naphthalene exposure: effects on gene expression — Skin Sensitisation (chairperson Dr D. Basketter, and proliferation in human cord blood cells. Journal of Unilever, UK; 1st meeting 23–24 July). Biochemical and Molecular Toxicology 17, 286–294. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alternatives to Laboratory Animals SAGE

ECVAM News & Views

Alternatives to Laboratory Animals , Volume 31 (5): 1 – Sep 1, 2003

Loading next page...
 
/lp/sage/ecvam-news-views-BtR5quIyic

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
SAGE
Copyright
© 2003 Fund for the Replacement of Animals in Medical Experiments
ISSN
0261-1929
eISSN
2632-3559
DOI
10.1177/026119290303100503
Publisher site
See Article on Publisher Site

Abstract

ATLA 31, 471, 2003 471 — Metabolism (chairperson Dr S. Coecke, ECVAM, ECVAM’s Scientific Advisory Committee Italy; 1st meeting 24–25 September). (ESAC) — Neurotoxicity (chairperson Dr S. Coecke, ECVAM, New ESAC member Italy; 1st meeting 1–2 October). Professor Michael Ryan has been nominated to represent Ireland on the ESAC. — Pyrogenicity (chairperson Dr R. Bos, RIVM, The Netherlands; 1st meeting 7–8 October). — Good Cell Culture Practice (chairpersons Dr G. Stacy, ECVAM Workshops NIBSC, UK and G. Gstraunthaler, University of Innsbruck, Austria; meeting 20–21 October). Acute systemic toxicity A workshop (chaired by Laura Gribaldo, ECVAM) on Strategies to Replace In Vivo Acute Systemic Toxicity Testing was hosted by ECVAM on 15–18 September, and Visit of Michael Balls was attended by 26 experts from industry, academia and regulatory authorities. The first head of ECVAM, Professor Michael Balls, vis- ited ECVAM on 21–22 October, to participate in the Rabies vaccines meeting of the Task Force on Good Cell Culture Practice, The report of ECVAM workshop 48 on Three Rs and to discuss further collaboration with FRAME. Approaches in the Quality Control of Inactivated Rabies Vaccines (Bruckner et al.) has been published in ATLA (31, 429–454, 2003). ECVAM Staff Andrew Worth, and his action on Development, valida- Joint Research Centre (JRC) Enlargement tion and dissemination of quantitative structure–activ- Action ity relationships (QSARs), joined ECVAM on 1 October On 24–26 September, ECVAM organised and hosted a practical training course on In Vitro Methods for Pyrogenicity Testing, in cooperation with the Pharm- aceutical Control and Development Laboratory ECVAM’s Website (Budapest, Hungary), the University of Konstanz (Germany), Novartis (Basel, Switzerland) and the Paul The ECVAM website (http://www.ecvam.jrc.it) is updated Ehrlich Institute (Langen, Germany). Thirteen partici- on a regular basis, and now includes a list of workshops pants from Bulgaria, Cyprus, Hungary and Slovenia and task force meetings organised by ECVAM. attended the course. In cooperation with the European Resource Centre for Alternatives (EURCA) and InterNICHE, ECVAM organ- ised and held a workshop on 18–20 October in Konstancin ECVAM Publications (Poland) on Alternatives to the Use of Animals in Higher Education. Nineteen participants attended the workshop, Pessina, A., Albella, B., Bayo, M., Bueren, J., Brantom, from Bosnia-Herzogowina, Croatia, the Czech Republic, P., Casati, S., Coroera, C., Gagliardi, G., Foti, P., Hungary, Latvia, Lithuania, Poland, Romania, Slovakia, Parchment, R., Parent-Massin, D., Schoeters, G., Sibiril, Slovenia and Turkey. The presentations are available on Y., Van Den Heuvel, R. & Gribaldo, L. (2003). Application the EURCA website (http://www.eurca.org). of the CFU-GM assay to predict acute drug-induced neu- tropenia: an international blind trial to validate a predic- tion model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicological Sciences 75, ECVAM Task Forces 355–367. Meetings of the following Task Forces have been held at Diodovich, C., Malerba, I., Bowe, G., Acquati, F., Bianchi, ECVAM. M.G., Taramelli, R., Parent-Massin, D. & Gribaldo, L. (2003). Naphthalene exposure: effects on gene expression — Skin Sensitisation (chairperson Dr D. Basketter, and proliferation in human cord blood cells. Journal of Unilever, UK; 1st meeting 23–24 July). Biochemical and Molecular Toxicology 17, 286–294.

Journal

Alternatives to Laboratory AnimalsSAGE

Published: Sep 1, 2003

There are no references for this article.